Clinical Trials Browser

Phase 2/3 × NETWORK × Granulocyte Colony-Stimulating Factor × Clear all

NCT00070187 2013-10-17

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Phase 2/3 Completed

Hodgkin Disease, Lymphoma, Recurrence